Advertisement Search POZ Search 573 results found Advanced Search #Gilead Sciences A collection of content all about Gilead Sciences. Gilead Sciences Awards $10M in 20 Grants for Racial Equity Jan 14, 2021: Building on the drugmaker’s HIV grants, this new funding is part of Gilead’s Racial Equity Community Impact Fund. Biktarvy HIV Medication Jun 20, 2019: Biktarvy was approved by the U.S. Food and Drug Administration in February 2018. It contains an integrase inhibitor, a nucleotide reverse tran... Descovy HIV Medication Oct 3, 2019: Descovy is a fixed-dose combination containing two approved HIV medications, tenofovir alafenamide (TAF) and emtricitabine. Stribild HIV Medication May 21, 2019: Stribild is a single-tablet regimen HIV Medication. Stribild was approved by the FDA in August 2012. Genvoya HIV Medication May 21, 2019: Genvoya is a single-tablet regimen HIV medication. Genvoya was approved by the FDA in November 2015. Behind a New $3.2M Partnership to Transform Black and Brown HIV Efforts Feb 2, 2021: Human Rights Campaign’s Alphonso David explains how a Gilead Sciences grant will help the LGBTQ group fight HIV and promote health equity. Gilead Mailers Violated HIV Customers’ Privacy, Claims Lawsuit May 26, 2020: Envelopes were sent to people in the pharma giant’s patient assistance program for PrEP. $350K in Grants for 16 Trans-Led Groups Fighting HIV May 15, 2020: Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them. New Twist in the Gilead Patent Lawsuit Over Truvada and Descovy to Prevent HIV Jan 7, 2021: The U.S. government and HIV drugmaker Gilead Sciences continue to fight over patents for Truvada and Descovy as PrEP. Tybost HIV Medication Jul 15, 2016: Tybost is a pharmacokinetic enhancer, a drug used to boost the blood levels of select HIV medications to make them more effective. Viread HIV Medication Feb 26, 2018: Viread is a nucleotide reverse transcriptase inhibitor HIV medication. Viread was approved by the FDA in 2001. Prevention: Generic Truvada Nov 16, 2020: The first generic Truvada is now available in the United States. Gilead’s $20M COVID-19 Fund Will Help HIV Nonprofits Apr 14, 2020: Groups already receiving grants from the pharma giant can apply for new funds during the coronavirus crisis. Join Celebs for the First HIV Stigma and Faith Summit [VIDEO] Feb 22, 2021: GLAAD’s free virtual summit runs from February 24 to 26. Here’s how to join discussions on faith and HIV stigma in the South. Supply of Our HIV and Hepatitis Meds Is Secure, Says Gilead Mar 26, 2020: The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment. Emtriva HIV Medication Jul 15, 2016: Emtriva is a nucleoside reverse transcriptase inhibitor HIV medication. Emtriva was approved by the FDA in 2003. Funders Stepping Up Apr 14, 2020: This week’s NMAC Hangout is with leaders committed to support the HIV infrastructure during and eventually after the COVID-19 outbreak. $5M Grant Launches a Faith Center to Tackle HIV in the South [VIDEO] Feb 23, 2021: With Gilead’s COMPASS Initiative funding, Wake Forest University School of Divinity inaugurates a faith coordinating center to fight HIV. How Comfortable Are Americans Around People With HIV? [VIDEO] Jul 27, 2020: The results of GLAAD’s first State of HIV Stigma Study coincide with news of a $9 million Gilead grant to fight HIV in the South. 1 2 3 4 5 6 7 8 9 10 11 ... 29 Next Advertisement Hot topics Forums: Support and discussion Blogs: The community speaks POZ Stories: Get inspired Magazine: Search the archives HIV: The Basics Recursos de VIH/SIDA en Español AIDS Is Everyday Ask POZ